Position in CHRS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,000
-$2,900 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#116
of 145 holders
Holding Since
Dec 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026COMMERCE BANK holds $32,396,174 across 26 Biotechnology names. CHRS ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,131 | $4,446,463 | |
| 2 | EXEL |
Exelixis, Inc.
|
78,937 | $4,294,961 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,033 | $3,990,231 | |
| 4 | MRNA |
Moderna, Inc.
|
55,243 | $3,868,667 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,461 | $2,848,043 | |
| 6 | TECH |
BIO-TECHNE Corp
|
33,609 | $2,374,475 | |
| 7 | INCY |
Incyte Corp
|
20,084 | $2,276,721 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
17,206 | $1,346,712 |
All Filings in CHRS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,000 | 10,000 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $16,900 | 10,000 | Shares | Sole | 2026-05-11 | |
| 2025-06-30 | $7,310 | 10,000 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $8,070 | 10,000 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $13,800 | 10,000 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||